Lördag 2 Augusti | 10:53:08 Europe / Stockholm

Prenumeration

2025-07-21 08:18:00

Redeye retains its positive view of Avensia despite slightly lowering our Base Case and forecasts. While not as solid as expected, Avensia continues to handle the soft market well, likely continuing to gain market share.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/